Damon Moderna Reports Earnings for First Quarter

The days of pandemic largesse are ending for Moderna, which the company has guided to in which everybody saw coming. This is on a product that did nearly $20 billion just a year ago. And so this is a company that will probably slip into being a loss making company again in just the next quarter after again making billions and billions of dollars. So it'll be interesting to see how that plays out.